The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization
Abstract
Background —The clinical benefits of lipid lowering with statins are attributed to changes in plaque composition leading to lesion stability, but supporting clinical data from human studies are lacking. Therefore, we investigated the effect of 3 months of pravastatin treatment on composition of human carotid plaques removed during carotid endarterectomy. Methods and Results —Consecutive patients with symptomatic carotid artery stenosis received 40 mg/d pravastatin (n=11) or no lipid-lowering therapy (n=13; control subjects) for 3 months before scheduled carotid endarterectomy. Carotid plaque composition was assessed with special stains and immunocytochemistry with quantitative image analysis. Plaques from the pravastatin group had less lipid by oil red O staining (8.2±8.4% versus 23.9±21.1% of the plaque area, P <0.05), less oxidized LDL immunoreactivity (13.3±3.6% versus 22.0±6.5%, P <0.001), fewer macrophages (15.0±10.2% versus 25.3±12.5%, P <0.05), fewer T cells (11.2±9.3% versus 24.3±13.4%, P <0.05), less matrix metalloproteinase 2 (MMP-2) immunoreactivity (3.6±3.9% versus 8.4±5.3%, P <0.05), greater tissue inhibitor of metalloproteinase 1 (TIMP-1) immunoreactivity (9.0±6.2% versus 3.1±3.9%, P <0.05), and a higher collagen content by Sirius red staining (12.4±3.1% versus 7.5±3.5%, P <0.005). Cell death by TUNEL staining was reduced in the pravastatin group (17.7±7.8% versus 32.0±12.6%, P <0.05). Conclusions —Pravastatin decreased lipids, lipid oxidation, inflammation, MMP-2, and cell death and increased TIMP-1 and collagen content in human carotid plaques, confirming its plaque-stabilizing effect in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
(1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250701 · Cited by 8,368
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Self-citationGalis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Davies, M. J., & Thomas, A. C. (1985) · Heart · doi:10.1136/hrt.53.4.363 · Cited by 1,985
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly
Burke, A. P., Farb, A., Malcom, G. T., Liang, Y.-H., Smialek, J., & Virmani, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361802 · Cited by 1,745
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
RICHARDSON, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90953-7 · Cited by 1,258
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V, & Fallon, J. T. (1994) · Circulation · doi:10.1161/01.cir.90.2.775 · Cited by 1,108
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Jukema, J. W., Bruschke, A. V. G., van Boven, A. J., Reiber, J. H. C., Bal, E. T., Zwinderman, A. H., Jansen, H., Boerma, G. J. M., van Rappard, F. M., & Lie, K. I. (1995) · Circulation · doi:10.1161/01.cir.91.10.2528 · Cited by 842
Shah, P. K., Falk, E., Badimón, J. J., Fernández‐Ortíz, A., Mailhac, A. C., Villareal-Levy, G., Fallon, J. T., Regnström, J., & Fuster, V. (1995) · PubMed · Cited by 722
Self-citationEffect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
MAAS Investigators (1994) · The Lancet · doi:10.1016/s0140-6736(94)92082-6 · Cited by 647
Aikawa, M., Rabkin, E., Okada, Y., Voglic, S. J., Clinton, S. K., Brinckerhoff, C. E., Sukhova, G. K., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.97.24.2433 · Cited by 555
Atherosclerotic plaque caps are locally weakened when macrophages density is increased
Lendon, C. L., Davies, M. J., Born, G. V. R., & Richardson, P. D. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90235-u · Cited by 547
Salonen, R., Nyyssönen, K., Porkkala, E., Rummukainen, J., Belder, R., Park, J.-S., & Salonen, J. T. (1995) · Circulation · doi:10.1161/01.cir.92.7.1758 · Cited by 540
Bustos, C., Hernández-Presa, M. A., Ortego, M., Tuñón, J., Ortega, L., Pérez, F., Díaz, C., Hernández, G., & Egido, J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00487-2 · Cited by 422
Inhibition of proinflammatory cytokine production by pravastatin
Rosenson, R. S., Tangney, C. C., & Casey, L. C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05917-0 · Cited by 376
Williams, J. K., Sukhova, G. K., Herrington, D. M., & Libby, P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00537-8 · Cited by 348
Xu, X.-P., Meisel, S. R., Ong, J. M., Kaul, S., Cercek, B., Rajavashisth, T. B., Sharifi, B., & Shah, P. K. (1999) · Circulation · doi:10.1161/01.cir.99.8.993 · Cited by 298
Self-citationRajavashisth, T. B., Xu, X.-P., Jovinge, S., Meisel, S., Xu, X.-O., Chai, N.-N., Fishbein, M. C., Kaul, S., Cercek, B., Sharifi, B., et al. (1999) · Circulation · doi:10.1161/01.cir.99.24.3103 · Cited by 281
Self-citationRedgrave, T. G., & Carlson, L. A. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40633-9 · Cited by 256
Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
Crisby, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06037-6 · Cited by 168
Self-citationBurleigh, M. C., Brigfs, A. D., Lendon, C. L., Davies, M. J., Born, G. V. R., & Richardson, P. D. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90039-j · Cited by 159
ASSOCIATION OF CORONARY PLAQUE RUPTURE AND ATHEROSCLEROTIC INFLAMMATION
Boyle, J. J. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199701)181:1<93::aid-path696>3.0.co;2-h · Cited by 150
Shiomi, M., Ito, T., Tsukada, T., Yata, T., Watanabe, Y., Tsujita, Y., Fukami, M., Fukushige, J.-I., Hosokawa, T., & Tamura, A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1938 · Cited by 128
Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients
Pfeffer, M. A., Sacks, F. M., Moyé, L. A., Brown, L., Rouleau, J. L., Hartley, L. H., Rouleau, J. R., Grimm, R. H., Sestier, F., Wickemeyer, W. J., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80478-0 · Cited by 125
Role of inflammation and metalloproteinases in plaque disruption and thrombosis
Shah, P. K. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300304 · Cited by 105
Self-citationKleinveld, H. A., Demacker, P. N. M., de Haan, A. F. J., & Stalenhoef, A. F. H. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00776.x · Cited by 93
Direct Effects of Statins on the Vascular Wall
Corsini, A., Pazzucconi, F., Arnaboldi, L., Pfister, P., Fumagalli, R., Paoletti, R., & Sirtori, C. R. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199805000-00017 · Cited by 86
PLAQUE DISRUPTION AND THROMBOSIS
Shah, P. K. (1999) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70074-6 · Cited by 82
Self-citationThe role of oxidized low-density lipoprotein in atherogenesis
Berliner, J. A., & Haberland, M. E. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199310000-00005 · Cited by 81
Plaque Disruption and Coronary Thrombosis: New Insight into Pathogenesis and Prevention
Shah, P. K. (1997) · Clinical Cardiology · doi:10.1002/j.1932-8737.1997.tb00011.x · Cited by 68
Self-citationLafont, A. M., & Libby, P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00216-2 · Cited by 62
Brown, B. G., Zhao, X., Sacco, D., & Albers, J. J. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.002053 · Cited by 38
Lipid-lowering therapy for patients with or at risk of coronary artery disease
KJEKSHUS, J. K., Pedersen, T. R., & Tobert, J. A. (1996) · Current Opinion in Cardiology · doi:10.1097/00001573-199607000-00011 · Cited by 21
Cited by
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Metadata
- Authors
- Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J.
- Venue
- Circulation
- Published
- 2001-02-20
- Volume
- 103
- Issue
- 7
- Pages
- 926-933
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1978644984
- Cited by
- 1,001
- References
- 44
- FWCI
- 63.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.